BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10504603)

  • 1. Strial dysfunction in the MRL-Fas mouse.
    Ruckenstein MJ; Milburn M; Hu L
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):452-6. PubMed ID: 10504603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural pathology in the stria vascularis of the MRL-Fasl(lpr) mouse.
    Ruckenstein MJ; Keithley EM; Bennett T; Powell HC; Baird S; Harris JP
    Hear Res; 1999 May; 131(1-2):22-8. PubMed ID: 10355601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
    Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The experimental research of inner ear metabolism and electrical physiology of autoimmune sensorineural hearing loss].
    Tan C; Cao Y; Hu P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Sep; 12(9):407-10. PubMed ID: 11263148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss.
    Kusakari C; Hozawa K; Koike S; Kyogoku M; Takasaka T
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():82-6. PubMed ID: 1416659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and morphological response of the stria vascularis following a sensorineural hearing loss.
    Hellier WP; Wagstaff SA; O'Leary SJ; Shepherd RK
    Hear Res; 2002 Oct; 172(1-2):127-36. PubMed ID: 12361875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunosuppression on the development of cochlear disease in the MRL-Fas(lpr) mouse.
    Ruckenstein MJ; Sarwar A; Hu L; Shami H; Marion TN
    Laryngoscope; 1999 Apr; 109(4):626-30. PubMed ID: 10201753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of strial melanin coincides with age-associated marginal cell loss and endocochlear potential decline.
    Ohlemiller KK; Rice ME; Lett JM; Gagnon PM
    Hear Res; 2009 Mar; 249(1-2):1-14. PubMed ID: 19141317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse.
    Wobig RJ; Kempton Jb; Trune DR
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):344-7. PubMed ID: 10504585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nimodipine on cochlear potentials and Na+/K(+)-ATPase activity in normal and hydropic cochleas of the albino guinea pig.
    van Benthem PP; Klis SF; Albers FW; de Wildt DJ; Veldman JE; Huizing EH; Smoorenburg GF
    Hear Res; 1994 Jun; 77(1-2):9-18. PubMed ID: 7928742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice.
    Lin DW; Trune DR
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):530-4. PubMed ID: 9374179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow cells as an origin of immune-mediated hearing loss.
    Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
    Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive endocochlear potential: mechanism of production by marginal cells of stria vascularis.
    Offner FF; Dallos P; Cheatham MA
    Hear Res; 1987; 29(2-3):117-24. PubMed ID: 3040655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody deposition in the stria vascularis of the MRL-Fas(lpr) mouse.
    Ruckenstein MJ; Hu L
    Hear Res; 1999 Jan; 127(1-2):137-42. PubMed ID: 9925025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral wall Na,K-ATPase and endocochlear potentials decline with age in quiet-reared gerbils.
    Schulte BA; Schmiedt RA
    Hear Res; 1992 Aug; 61(1-2):35-46. PubMed ID: 1326507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the endocochlear potential caused by Cs(+) in the perilymph can be explained by the five-compartment model of the stria vascularis.
    Kakigi A; Takeuchi S; Ando M; Higashiyama K; Azuma H; Sato T; Takeda T
    Hear Res; 2002 Apr; 166(1-2):54-61. PubMed ID: 12062758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential.
    Shibata T; Hibino H; Doi K; Suzuki T; Hisa Y; Kurachi Y
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1038-48. PubMed ID: 16822945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
    Trune DR; Kempton JB; Kessi M
    Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune disease and cochlear pathology in the C3H/lpr strain mouse.
    Trune DR; Craven JP; Morton JI; Mitchell C
    Hear Res; 1989 Mar; 38(1-2):57-66. PubMed ID: 2708160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.